在这种情况下,聚合纳米能增强了辐射诱导的抗瘤免疫力
Jialong Xu1, Chao Wang1, Li Zhang2
1Medical School of Nanjing University, Nanjing 210093, China.
ACS applied materials & interfaces
|June 28, 2024
概括
这项研究引入了一种新的纳米材料策略,该策略集成*in situ*以提高放射治疗的有效性. 这种方法增强了瘤的保留,并增强了免疫系统.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 癌症研究 癌症研究
背景情况:
- 放射治疗 (RT) 的有效性受到纳米辐射敏感剂积累不良和抗瘤免疫激活不足的限制.
- 小纳米粒子面临着血管逆流和组织扩散的挑战,减少了它们的治疗潜力.
- 激活STING通路对于引起强大的抗癌免疫反应至关重要.
研究的目的:
- 开发一种智能纳米材料系统,用于*in situ*聚合,以提高RT的有效性.
- 为了改善纳米辅助剂在瘤中的保留.
- 研究该系统通过STING通路激活抗瘤免疫力的潜力.
主要方法:
- 设计和合成能够进行*in situ*聚合的响应pH的纳米辅助剂 (MnAuNP-C&B).
- 在癌细胞和瘤中评估纳米粒子聚合,保留时间和放射敏感化效应.
- 评估Mn2+释放,STING通路激活,以及随后的抗瘤免疫反应.
主要成果:
- 聚合的MnAuNP-C&B系统证明在癌细胞和瘤中保持时间长,克服了小纳米颗粒的局限性.
- 在RT期间,观察到MnAuNP-C&B系统显著增强了放射敏感化效应.
- 响应pH的MnAuNP-C&B的分解触发了Mn2+的释放,激活了STING通路并促进了抗瘤免疫力.
结论:
- 纳米辅助剂的"现场"聚合是一种可行的策略,可以改善RT结果.
- 该MnAuNP-C&B系统有效地增强了放射敏感性,并刺激了抗瘤免疫力.
- 这种方法提供了一种有希望的方法,通过将放射敏感化与免疫激活相结合来抑制瘤生长.
相关概念视频
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.